Press release
Antisense and RNAi Therapeutics Market Projected to Achieve USD 18.43 Billion in Revenue by 2032 | PMR
Antisense and RNAi Therapeutics Market
The global healthcare landscape is on the brink of a transformative shift as Antisense and RNA interference (RNAi) therapeutics advance toward becoming mainstream treatments. As leading biopharmaceutical companies and cutting-edge research institutions announce groundbreaking developments, the Antisense and RNAi Therapeutics Market is projected to experience unprecedented growth, potentially revolutionizing patient care and offering new hope for previously untreatable diseases.
๐๐๐ญ ๐๐ฑ๐๐ฅ๐ฎ๐ฌ๐ข๐ฏ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐ฌ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.polarismarketresearch.com/industry-analysis/antisense-and-rnai-therapeutics-market/request-for-sample
๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐ฏ๐ ๐๐ก๐๐ซ๐๐ฉ๐ข๐๐ฌ ๐๐๐ฏ๐ ๐ญ๐ก๐ ๐๐๐ฒ ๐๐จ๐ซ ๐๐๐ซ๐ ๐๐ญ๐๐ ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ๐ฌ:
Antisense and RNAi therapeutics represent a novel approach in the field of genetic medicine. Unlike traditional treatments that often address symptoms, these therapies target the underlying genetic causes of diseases. By modulating gene expression, they offer highly specific interventions that can silence or alter the production of disease-causing proteins. This precision has the potential to significantly reduce side effects and improve patient outcomes.
๐๐๐๐๐ง๐ญ ๐๐ข๐ฅ๐๐ฌ๐ญ๐จ๐ง๐๐ฌ ๐๐ง๐ ๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐ซ๐จ๐ฌ๐ฉ๐๐๐ญ๐ฌ
๐๐๐ฏ๐๐ซ๐๐ฅ ๐ค๐๐ฒ ๐ฆ๐ข๐ฅ๐๐ฌ๐ญ๐จ๐ง๐๐ฌ ๐ก๐๐ฏ๐ ๐๐๐๐ง ๐๐๐ก๐ข๐๐ฏ๐๐ ๐ซ๐๐๐๐ง๐ญ๐ฅ๐ฒ:
FDA Approvals: The U.S. Food and Drug Administration (FDA) has granted approval to several antisense and RNAi-based drugs, paving the way for their use in clinical settings. Notable approvals include therapies for spinal muscular atrophy (SMA), amyloidosis, and hypercholesterolemia.
Clinical Trials: Numerous clinical trials are underway, investigating the efficacy of these therapies in treating a broad spectrum of conditions, from rare genetic disorders to more common diseases like cancer and cardiovascular ailments.
Partnerships and Collaborations: Major pharmaceutical companies are increasingly forming strategic alliances with biotech firms specializing in RNA-based technologies. These collaborations are accelerating the development and commercialization of new therapies.
๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ง๐ ๐๐๐จ๐ง๐จ๐ฆ๐ข๐ ๐๐ฆ๐ฉ๐๐๐ญ:
The Antisense and RNAi Therapeutics Market is poised for rapid expansion. Analysts predict a compound annual growth rate (CAGR) of over 20% in the next decade, driven by ongoing advancements in technology, increased investment in research and development, and growing recognition of the clinical benefits of these therapies.
๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ฉ๐จ๐ซ๐ญ:ย https://www.polarismarketresearch.com/buy/3489/2
๐๐จ๐ฆ๐ ๐จ๐ ๐ญ๐ก๐ ๐ฆ๐๐ฃ๐จ๐ซ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐จ๐ฉ๐๐ซ๐๐ญ๐ข๐ง๐ ๐ข๐ง ๐ญ๐ก๐ ๐ ๐ฅ๐จ๐๐๐ฅ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ข๐ง๐๐ฅ๐ฎ๐๐:
Alnylam Pharmaceuticals, Inc.
Arbutus Biopharma
Benitec Biopharma Inc.
GSK plc
Ionis Pharmaceuticals, Inc
Olix Pharmaceuticals, Inc.
Percheron Therapeutics Limited
Sanofi
Sarepta Therapeutics
Silence Therapeutics
๐๐ง๐ญ๐ข๐ฌ๐๐ง๐ฌ๐ ๐๐ง๐ ๐๐๐๐ข ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
The antisense RNA segment dominated the market in 2023, driven by conducting tests on it to regulate various conditions.
The intrathecal injections segment led the market in 2023 and is expected to maintain its dominance due to its application in pain management and introduction of medications to fight particular infections.
North America holds a significant revenue share in the global antisense and RNAi therapeutics market, driven by major biopharmaceutical companies and heavy investment made by them in activities such as research and development.ย ย
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ก๐ ๐๐จ๐ฆ๐ฉ๐ฅ๐๐ญ๐ ๐๐จ๐ฆ๐ฉ๐ซ๐๐ก๐๐ง๐ฌ๐ข๐ฏ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ซ๐:ย https://www.polarismarketresearch.com/industry-analysis/antisense-and-rnai-therapeutics-market
Polaris Market Research has segmented the Antisense and RNAi therapeutics market report based on technology, route of administration, application, and region:
Antisense and RNAi therapeutics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)
Antisense RNA
RNA Interference
Others
Antisense and RNAi therapeutics, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)
Intrathecal Injections
Subcutaneous Injections
Intravenous Injections
Other Delivery Methods
Antisense and RNAi therapeutics, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Neurodegenerative Disorders
Genetic Disease
Cancer
Cardiometabolic & Renal Disorders
Infectious Disease
Skin Disorders
Respiratory Disorders
Ocular Disorders
Antisense and RNAi therapeutics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
๐๐จ๐ซ๐ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ญ๐๐ฌ๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐จ๐ฅ๐๐ซ๐ข๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
๐๐๐๐ข๐๐๐ฅ ๐๐ญ๐ข๐๐ค ๐๐จ ๐๐ค๐ข๐ง ๐๐๐ก๐๐ฌ๐ข๐ฏ๐๐ฌ ๐๐๐ซ๐ค๐๐ญ:ย https://www.polarismarketresearch.com/industry-analysis/medical-stick-to-skin-adhesives-market
๐๐๐ฌ๐๐ซ ๐๐๐ฉ๐ญ๐ฎ๐ซ๐ ๐๐ข๐๐ซ๐จ๐๐ข๐ฌ๐ฌ๐๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ:ย https://www.polarismarketresearch.com/industry-analysis/laser-capture-microdissection-market
๐๐ข๐ซ๐๐ฅ ๐๐ฅ๐๐๐ซ๐๐ง๐๐ ๐๐๐ซ๐ค๐๐ญ:ย https://www.polarismarketresearch.com/industry-analysis/viral-clearance-market
๐๐ง๐๐ค๐ ๐๐ง๐ญ๐ข๐ฏ๐๐ง๐จ๐ฆ ๐๐๐ซ๐ค๐๐ญ:ย https://www.polarismarketresearch.com/industry-analysis/snake-antivenom-market
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ง๐๐จ:
Polaris Market Research
30 Wall Street, 8th Floor,
New York City, NY 10005,
United States
Phone:+1-929 297-9727
Email: sales@polarismarketresearch.com
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antisense and RNAi Therapeutics Market Projected to Achieve USD 18.43 Billion in Revenue by 2032 | PMR here
News-ID: 3544802 • Views: โฆ
More Releases from Polaris Market Research & Consulting
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected toโฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโฆ
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA โฆ
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, andโฆ
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca โฆ
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,โฆ
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca โฆ
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
โข 70% efforts of Primary Research
โข 15% efforts of Secondary Research
โข 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limitedโฆ
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin โฆ
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
โข The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
โข Expected exponentialโฆ
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe โฆ
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers aโฆ
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te โฆ
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and mayโฆ
